Market Closed -
Nasdaq
04:00:00 2024-05-17 pm EDT
|
5-day change
|
1st Jan Change
|
23.02
USD
|
+0.77%
|
|
+7.92%
|
+191.76%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
125.1
|
388.7
|
22.3
|
88.03
|
347.3
|
-
|
-
|
Enterprise Value (EV)
1 |
125.1
|
304
|
-15.95
|
88.03
|
130.3
|
347.3
|
347.3
|
P/E ratio
|
-1.94
x
|
-2.92
x
|
-0.47
x
|
-1.28
x
|
-4.96
x
|
-5.86
x
|
-4.78
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
63.1
x
|
219
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
63.1
x
|
219
x
|
EV / EBITDA
|
-
|
-8,339,116
x
|
345,718
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-8.42
x
|
0.34
x
|
-
|
-1.86
x
|
-4.46
x
|
-3.39
x
|
FCF Yield
|
-
|
-11.9%
|
291%
|
-
|
-53.7%
|
-22.4%
|
-29.5%
|
Price to Book
|
-
|
4.27
x
|
0.5
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,250
|
4,952
|
4,618
|
11,158
|
15,086
|
-
|
-
|
Reference price
2 |
100.1
|
78.50
|
4.829
|
7.890
|
23.02
|
23.02
|
23.02
|
Announcement Date
|
6/8/21
|
3/18/22
|
3/8/23
|
3/4/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
5.5
|
1.582
|
EBITDA
|
-
|
-36.46
|
-46.13
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-36.83
|
-51.2
|
-68.86
|
-72.8
|
-81.73
|
-107.3
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-1,486.02%
|
-6,780.88%
|
Earnings before Tax (EBT)
1 |
-
|
-30.64
|
-37.68
|
-64.46
|
-67.71
|
-77.12
|
-107
|
Net income
1 |
-31.67
|
-30.64
|
-37.68
|
-64.46
|
-67.71
|
-77.12
|
-102.9
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-1,402.24%
|
-6,501.98%
|
EPS
2 |
-51.70
|
-26.90
|
-10.30
|
-6.180
|
-4.642
|
-3.926
|
-4.814
|
Free Cash Flow
1 |
-
|
-36.11
|
-46.43
|
-
|
-69.99
|
-77.88
|
-102.5
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-1,415.98%
|
-6,479.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/8/21
|
3/18/22
|
3/8/23
|
3/4/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-12.44
|
-11.87
|
-
|
-17.55
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-12.08
|
-12.78
|
-11.96
|
-12.71
|
-13.75
|
-13.95
|
-17.83
|
-19.36
|
-17.72
|
-15.07
|
-18.1
|
-19.1
|
-19.94
|
-16.07
|
-16.78
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-9.057
|
-2.207
|
-10.4
|
-11.86
|
-13.21
|
-14.26
|
-16.08
|
-17.54
|
-16.58
|
-13.73
|
-16.77
|
-17.76
|
-19.05
|
-16.07
|
-16.78
|
Net income
1 |
-9.057
|
-2.207
|
-10.4
|
-11.86
|
-13.21
|
-14.26
|
-16.08
|
-17.54
|
-16.58
|
-13.73
|
-16.77
|
-17.76
|
-19.05
|
-16.07
|
-16.78
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-2.500
|
-0.6000
|
-2.900
|
-3.200
|
-3.600
|
-1.600
|
-1.500
|
-1.600
|
-1.500
|
-1.030
|
-1.124
|
-1.200
|
-1.268
|
-0.8300
|
-0.8600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/22
|
5/12/22
|
8/12/22
|
11/10/22
|
3/8/23
|
5/12/23
|
8/11/23
|
11/9/23
|
3/4/24
|
5/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
84.7
|
38.3
|
-
|
217
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-36.1
|
-46.4
|
-
|
-70
|
-77.9
|
-103
|
ROE (net income / shareholders' equity)
|
-
|
-78.3%
|
-71.4%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
18.40
|
9.690
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-29.60
|
-12.60
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2.43
|
0.58
|
0.27
|
0.58
|
0.92
|
1.5
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
16.81%
|
94.47%
|
Announcement Date
|
6/8/21
|
3/18/22
|
3/8/23
|
3/4/24
|
-
|
-
|
-
|
Last Close Price
23.02
USD Average target price
64.17
USD Spread / Average Target +178.74% Consensus |
1st Jan change
|
Capi.
|
---|
| +191.76% | 347M | | +32.09% | 693B | | +29.39% | 584B | | -1.34% | 372B | | +20.34% | 332B | | +7.39% | 294B | | +14.25% | 239B | | -3.03% | 211B | | +10.02% | 210B | | +8.49% | 168B |
Other Pharmaceuticals
|